LBRX

LB PHARMACEUTICALS INC

NasdaqGM · Healthcare

$33.43

+2.63% today

last filing 2025-09-12Pro sees filings in ~15 min

Price

hover · 4 moves explained

6 buys4 8-K

Analyst consensus

Strong Buy

$45.00target+34.6%vs $33.43 today

$34.00 low today target$78.00 high

7 analysts · ~12-month consensus · as of Jul 8. Relayed analyst opinion, which tends to run optimistic — not our forecast or advice.

Earnings

Beat 0 of last 2

Earnings per share · actual vs forecast

Q3 '25

−$0.61

exp −$0.28

Q4 '25-42.1%

−$0.45

exp −$0.32

Type	Date	Insider	Title	Of stake	Shares	Price	Value
Buy	2025-09-16	Pontifax Management 4 G.P. (2015) Ltd.	10% owner	71%Indirect	1,000,000	$15.00	$15.00M
Convert	2025-09-16	Pontifax Management 4 G.P. (2015) Ltd.	10% owner	—Indirect	411,681	—	—
Buy	2025-09-16	Nussbaum Ran	Director	71%Indirect	1,000,000	$15.00	$15.00M
Convert	2025-09-16	Nussbaum Ran	Director	—Indirect	411,681	—	—
Buy	2025-09-16	Deep Track Biotechnology Master Fund, Ltd.	10% owner	100%Indirect	666,666	$15.00	$10.00M

Buy

Pontifax Management 4 G.P. (2015) Ltd.

10% owner · 71% of stake · 2025-09-16

$15.00M

1,000,000 @ $15.00

Convert

Pontifax Management 4 G.P. (2015) Ltd.

10% owner · 2025-09-16

—

411,681 shares

Buy

Nussbaum Ran

Director · 71% of stake · 2025-09-16

$15.00M

1,000,000 @ $15.00

Convert

Nussbaum Ran

Director · 2025-09-16

—

411,681 shares

Buy

Deep Track Biotechnology Master Fund, Ltd.

10% owner · 100% of stake · 2025-09-16

$10.00M

666,666 @ $15.00

6 more transactions on ProFull insider transaction history is a Pro feature.

Upgrade →